Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients

被引:108
|
作者
Lanchou, J [1 ]
Corbel, M
Tanguy, M
Germain, N
Boichot, E
Theret, N
Clement, B
Lagente, V
Malledant, Y
机构
[1] Univ Rennes, INSERM U456, Rennes, France
[2] CHU Rennes, Hop Pontchaillou, Serv Reanimat Chirurg, Rennes, France
关键词
matrix metalloproteinases; tissue inhibitor of matrix metalloproteinases; acute respiratory distress syndrome; acute lung injury;
D O I
10.1097/01.CCM.0000048626.02184.F8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Matrix metalloproteinases (MMPs) are known to be involved in degradation of extracellular matrix. We aimed to assess the role of MMPs and their natural inhibitors (TIMPs) in the genesis and the evolution of acute respiratory distress syndrome (ARDS). Design: Prospective, clinical study. Setting: Intensive care unit of a university hospital. Patients: Twenty-one patients were assigned to three different groups: Group 1 patients developed ARDS that rapidly resolved in <4 days; Group 2 patients developed ARDS lasting >8 days; Group 3 (control group) patients had clinical criteria for hospital-acquired pneumonia without ARDS. Intervention: Bronchoalveolar lavages were performed on day 0 of the onset of ARDS and on days 4, 8, and 12 for unresolving ARDS. For group 3, the bronchoalveolar lavages were performed on day 0 of the pneumonia. On these bronchoalveolar lavage fluids, we measured the amount of MMP-9 and -2 and their inhibitors TIMP-1 and -2. Measurements and Main Results: The amount of MMP-9 measured by enzyme-linked immunosorbent assay was significantly lower in the bronchoalveolar lavages from patients with ARDS (group 1 and group 2) compared with the control group (p < .01) throughout the study. The ratio MMP-9/TIMP-1 was also significantly smaller and was less than one in the two ARDS groups (p < .05) compared with the control group (group 3), where this ratio was greater than one. In the second bronchoalveolar lavages, this ratio was greater than one only in the ARDS group that rapidly resolved (group 1), whereas it stayed less than one when the ARDS was lasting (group 2). Concerning the quantity of MMP-2 and the ratio MMP-2/TIMP-2, there was no statistical difference between the three groups throughout the study. Using zymography, there was no significant difference in the amounts of active and latent MMP-9 between the three groups. Moreover, no significant difference in the quantity of latent and active MMP-2 in the three groups was noted. Conclusion: These results suggest that the MMP-9 level and MMP-9/TIMP-1 ratio play a role in the pathogenesis of ARDS and, namely, the imbalance between MMP-9 and TIMP-1 would participate in airway remodeling leading to either short- or long-course ARDS. The ratio MMP-9/TIMP-1 could be a predictive factor of the ARDS evolution.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 50 条
  • [41] Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1,-2, and-3 in benign and malignant tumours of the salivary gland
    Nagel, H
    Laskawi, R
    Wahlers, A
    Hemmerlein, B
    HISTOPATHOLOGY, 2004, 44 (03) : 222 - 231
  • [42] Clinical significance of MMP-2, MMP-9, their tissue inhibitors TIMP-1 and TIMP-2 and innate immune cells in patients with colorectal cancer
    Mrakovcic-Sutic, Ines
    Bulog, Aleksandar
    Sutic, Ivana
    Pavisic, Valentino
    Udovic, Ingrid Sutic
    Letica, Ludvig
    Brekalo, Zdrinko
    Kovacevic, Miljenko
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 89 - 90
  • [43] MATRIX METALLOPROTEINASES (MMP-2, 3, 7, 9) AND THEIR TISSUE INHIBITORS (TIMP-1, 2) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Zakiyanov, Oskar
    Svobodova, Barbora
    Hruskova, Zdenka
    Pesickova, Satu Sinikka
    Konopasek, Pavel
    Vachek, Jan
    Kriha, Vtezslav
    Kalousova, Marta
    Zima, Tomas
    Tesar, Vladimir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [44] MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma
    Zhang, Wen-jing
    Song, Bing
    Yang, Tao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10675 - 10681
  • [45] Evaluation of Matrix Metalloproteinase-2 (MMP-2) and-9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia
    Tuna, Gamze
    Yener, Gorsev Gulmen
    Oktay, Gulgun
    Islekel, Gul Huray
    Kirkali, Fatos Guldal
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 66 (03) : 1265 - 1273
  • [46] Identification of matrix metalloproteinase (MMP-2, MMP-9) and their cognitive inhibitors (TIMP-1, TIMP-2) in the male canine reproductive system
    Warinrak, C.
    Cheng, F. P.
    REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 : 521 - 522
  • [47] MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors
    Jinga, D. C.
    Blidaru, A.
    Condrea, Ileana
    Ardeleanu, Carmen
    Dragomir, Cristina
    Szegli, Geza
    Stefanescu, Maria
    Matache, Cristiana
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2006, 10 (02) : 499 - 510
  • [48] Evaluation of MMP-9 and MMP-2 and their suppressor TIMP-1 and TIMP-2 in adenocarcinoma of esophagogastric junction
    Lu, Xiaofei
    Duan, Lingling
    Xie, Hongqin
    Lu, Xiaoxia
    Lu, Daolin
    Lu, Daopeng
    Jiang, Nan
    Chen, Yuxin
    ONCOTARGETS AND THERAPY, 2016, 9 : 4343 - 4349
  • [49] Immunohistochemical localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the forming rat incisor
    Goldberg, M
    Septier, D
    Bourd, K
    Hall, R
    George, A
    Goldberg, H
    Menashi, S
    CONNECTIVE TISSUE RESEARCH, 2003, 44 (3-4) : 143 - 153
  • [50] Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine
    Eissa, Sanaa
    Ali-Labib, Randa
    Swellam, Menha
    Bassiony, Manal
    Tash, Fathy
    El-Zayat, Tarek Mostafa
    EUROPEAN UROLOGY, 2007, 52 (05) : 1388 - 1397